EconPapers    
Economics at your fingertips  
 

Structural basis of organic cation transporter-3 inhibition

Basavraj Khanppnavar, Julian Maier, Freja Herborg, Ralph Gradisch, Erika Lazzarin, Dino Luethi, Jae-Won Yang, Chao Qi, Marion Holy, Kathrin Jäntsch, Oliver Kudlacek, Klaus Schicker, Thomas Werge, Ulrik Gether, Thomas Stockner (), Volodymyr M. Korkhov () and Harald H. Sitte ()
Additional contact information
Basavraj Khanppnavar: Laboratory of Biomolecular Research, Paul Scherrer Institute
Julian Maier: Medical University of Vienna
Freja Herborg: University of Copenhagen
Ralph Gradisch: Medical University of Vienna
Erika Lazzarin: Medical University of Vienna
Dino Luethi: Medical University of Vienna
Jae-Won Yang: Medical University of Vienna
Chao Qi: Laboratory of Biomolecular Research, Paul Scherrer Institute
Marion Holy: Medical University of Vienna
Kathrin Jäntsch: Medical University of Vienna
Oliver Kudlacek: Medical University of Vienna
Klaus Schicker: Medical University of Vienna
Thomas Werge: Institute of Biological Psychiatry, Mental Health Services Copenhagen
Ulrik Gether: University of Copenhagen
Thomas Stockner: Medical University of Vienna
Volodymyr M. Korkhov: Laboratory of Biomolecular Research, Paul Scherrer Institute
Harald H. Sitte: Medical University of Vienna

Nature Communications, 2022, vol. 13, issue 1, 1-13

Abstract: Abstract Organic cation transporters (OCTs) facilitate the translocation of catecholamines, drugs and xenobiotics across the plasma membrane in various tissues throughout the human body. OCT3 plays a key role in low-affinity, high-capacity uptake of monoamines in most tissues including heart, brain and liver. Its deregulation plays a role in diseases. Despite its importance, the structural basis of OCT3 function and its inhibition has remained enigmatic. Here we describe the cryo-EM structure of human OCT3 at 3.2 Å resolution. Structures of OCT3 bound to two inhibitors, corticosterone and decynium-22, define the ligand binding pocket and reveal common features of major facilitator transporter inhibitors. In addition, we relate the functional characteristics of an extensive collection of previously uncharacterized human genetic variants to structural features, thereby providing a basis for understanding the impact of OCT3 polymorphisms.

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41467-022-34284-8 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34284-8

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-34284-8

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34284-8